Home

Junior Psychologie Handel ioannis tarnanas altoida Teilweise Teilweise Philosophisch

Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni

Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference

Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly  Venture Partners | fyrfly.vc
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc

New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status -  Being Patient
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient

Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED
Interview with Dr. Panagiotis Vlamos and Dr. Ioannis Tarnanas - IED

Using augmented reality, Altoida is identifying the likely onset of  neurodegenerative diseases | TechCrunch
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch

Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference

Using augmented reality, Altoida is identifying the likely onset of  neurodegenerative diseases | TechCrunch
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch

Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida

New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status -  Being Patient
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient

Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum

Greek Researcher Receives Top European Innovation Award (video)
Greek Researcher Receives Top European Innovation Award (video)

Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida

Alzheimer's detection platform Altoida raises $6.3M in Series A funding |  MobiHealthNews
Alzheimer's detection platform Altoida raises $6.3M in Series A funding | MobiHealthNews

Using a Digital Neuro Signature to measure longitudinal individual-level  change in Alzheimer's disease: the Altoida large cohort study | npj Digital  Medicine
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine

Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease

Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida

Altoida secures funding and research partnership with Eisai Innovation –  Venturelab
Altoida secures funding and research partnership with Eisai Innovation – Venturelab

Venture Kick on Twitter: "Smart and personalized brain health gets a boost:  TOP 100 Swiss startup @Altoida raises funding and cooperates with strategic  investor @Eisai_SDGs from Japan. Congratulations to founder Ioannis Tarnanas
Venture Kick on Twitter: "Smart and personalized brain health gets a boost: TOP 100 Swiss startup @Altoida raises funding and cooperates with strategic investor @Eisai_SDGs from Japan. Congratulations to founder Ioannis Tarnanas

Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum

Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award |  ellines.com
Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com

Ioannis Tarnanas's email & phone | Altoida's Founder email
Ioannis Tarnanas's email & phone | Altoida's Founder email

A brain fitbit that can spot Alzheimer's with up to 94% accuracy
A brain fitbit that can spot Alzheimer's with up to 94% accuracy